The protocol involves following criteria: 1. Remodeling the respiratory passage by inhibiting transforming growth factor β1/Smad signal pathway. 2. Relaxing the respiratory smooth muscles. 3. Reducing the oxidative stress marker reactive oxygen species. 4. Activating Nuclear Factor E2-Related Factor 2. 5. Managing the steps of Arachidonic Acid Metabolism Pathway. 6. Managing the Imbalance of T-helper-1 & T-helper-2 cytokines. 7. Decreasing the ratio of GATA binding protein-3 / transcription factor T-box expressed in T-cells expression levels. 8. Inhibition of Signal transducer and activator of transcription 6 expression. 9. Regulating & inhibiting the activation of Mitogen-activated protein kinase and Nuclear factor-κappa-B signaling pathways. 10. Increasing the regulatory-T cells and enhancing Transcription Factor Fork-Head Box P3 mRNA expression. 11. Inhibiting the mast cell de-granulation. 12. Inhibiting the functional differentiation of pulmonary immature DC to mature DC. 13. Reducing the dependence on Corticosteroids. 14. Improvement in symptom syndrome of Asthma. 15. Reducing the levels of Interleukin-4, and that of Interferon-γ and PEFR.